NCT01694680View on ClinicalTrials.gov

Intervention Trial in Early Age-related Macular Degeneration

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Age-related Macular Degeneration (AMD)
Interventions
DIETARY_SUPPLEMENT

Lutein-enriched-egg beverage (NWT-02)

Lutein, zeaxanthin and DHA-enriched-egg yolk combined with buttermilk beverage

DIETARY_SUPPLEMENT

Placebo

color-, taste- and energy-matched powder without enriched egg-yolk

Trial Locations (4)

Unknown

TUFTS University, Boston

Universitäts Augenklinik - Bonn, Bonn

Manchester Royal Eye Hospital - Manchester, Manchester

6525EX

Radboud University Hospital, Nijmegen

All Listed Sponsors
collaborator

Sprim Advanced Life Sciences

OTHER

lead

Newtricious R&D BV

INDUSTRY

NCT01694680 - Intervention Trial in Early Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter